[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Microneedle Flu Vaccine Market Research Report 2024(Status and Outlook)

July 2024 | 120 pages | ID: G6B2C67A67E8EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.

The Global Microneedle Flu Vaccine Market Size was estimated at USD 1480.14 million in 2023 and is projected to reach USD 2040.88 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.

This report provides a deep insight into the global Microneedle Flu Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Microneedle Flu Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Microneedle Flu Vaccine market in any manner.

Global Microneedle Flu Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

GC Pharma

Debiotech

NanoPass Technologies

Corium International

Becton Dickinson and Company

FluGen

CosMED Pharmaceuticals

Microdermics and OraSure Technologies

Market Segmentation (by Type)

Solid Microneedle

Hollow Microneedle

Coated Microneedle

Dissolving Microneedle

Market Segmentation (by Application)

Influenza A

Influenza B

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Microneedle Flu Vaccine Market
  • Overview of the regional outlook of the Microneedle Flu Vaccine Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Microneedle Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Microneedle Flu Vaccine
1.2 Key Market Segments
  1.2.1 Microneedle Flu Vaccine Segment by Type
  1.2.2 Microneedle Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MICRONEEDLE FLU VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Microneedle Flu Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Microneedle Flu Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MICRONEEDLE FLU VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Global Microneedle Flu Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Microneedle Flu Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Microneedle Flu Vaccine Sales Sites, Area Served, Product Type
3.6 Microneedle Flu Vaccine Market Competitive Situation and Trends
  3.6.1 Microneedle Flu Vaccine Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 MICRONEEDLE FLU VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Microneedle Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MICRONEEDLE FLU VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Microneedle Flu Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Microneedle Flu Vaccine Price by Type (2019-2024)

7 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microneedle Flu Vaccine Market Sales by Application (2019-2024)
7.3 Global Microneedle Flu Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Microneedle Flu Vaccine Sales Growth Rate by Application (2019-2024)

8 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY REGION

8.1 Global Microneedle Flu Vaccine Sales by Region
  8.1.1 Global Microneedle Flu Vaccine Sales by Region
  8.1.2 Global Microneedle Flu Vaccine Sales Market Share by Region
8.2 North America
  8.2.1 North America Microneedle Flu Vaccine Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Microneedle Flu Vaccine Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Microneedle Flu Vaccine Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Microneedle Flu Vaccine Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Microneedle Flu Vaccine Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Sanofi
  9.1.1 Sanofi Microneedle Flu Vaccine Basic Information
  9.1.2 Sanofi Microneedle Flu Vaccine Product Overview
  9.1.3 Sanofi Microneedle Flu Vaccine Product Market Performance
  9.1.4 Sanofi Business Overview
  9.1.5 Sanofi Microneedle Flu Vaccine SWOT Analysis
  9.1.6 Sanofi Recent Developments
9.2 GC Pharma
  9.2.1 GC Pharma Microneedle Flu Vaccine Basic Information
  9.2.2 GC Pharma Microneedle Flu Vaccine Product Overview
  9.2.3 GC Pharma Microneedle Flu Vaccine Product Market Performance
  9.2.4 GC Pharma Business Overview
  9.2.5 GC Pharma Microneedle Flu Vaccine SWOT Analysis
  9.2.6 GC Pharma Recent Developments
9.3 Debiotech
  9.3.1 Debiotech Microneedle Flu Vaccine Basic Information
  9.3.2 Debiotech Microneedle Flu Vaccine Product Overview
  9.3.3 Debiotech Microneedle Flu Vaccine Product Market Performance
  9.3.4 Debiotech Microneedle Flu Vaccine SWOT Analysis
  9.3.5 Debiotech Business Overview
  9.3.6 Debiotech Recent Developments
9.4 NanoPass Technologies
  9.4.1 NanoPass Technologies Microneedle Flu Vaccine Basic Information
  9.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Overview
  9.4.3 NanoPass Technologies Microneedle Flu Vaccine Product Market Performance
  9.4.4 NanoPass Technologies Business Overview
  9.4.5 NanoPass Technologies Recent Developments
9.5 Corium International
  9.5.1 Corium International Microneedle Flu Vaccine Basic Information
  9.5.2 Corium International Microneedle Flu Vaccine Product Overview
  9.5.3 Corium International Microneedle Flu Vaccine Product Market Performance
  9.5.4 Corium International Business Overview
  9.5.5 Corium International Recent Developments
9.6 Becton Dickinson and Company
  9.6.1 Becton Dickinson and Company Microneedle Flu Vaccine Basic Information
  9.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Overview
  9.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product Market Performance
  9.6.4 Becton Dickinson and Company Business Overview
  9.6.5 Becton Dickinson and Company Recent Developments
9.7 FluGen
  9.7.1 FluGen Microneedle Flu Vaccine Basic Information
  9.7.2 FluGen Microneedle Flu Vaccine Product Overview
  9.7.3 FluGen Microneedle Flu Vaccine Product Market Performance
  9.7.4 FluGen Business Overview
  9.7.5 FluGen Recent Developments
9.8 CosMED Pharmaceuticals
  9.8.1 CosMED Pharmaceuticals Microneedle Flu Vaccine Basic Information
  9.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Overview
  9.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Market Performance
  9.8.4 CosMED Pharmaceuticals Business Overview
  9.8.5 CosMED Pharmaceuticals Recent Developments
9.9 Microdermics and OraSure Technologies
  9.9.1 Microdermics and OraSure Technologies Microneedle Flu Vaccine Basic Information
  9.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Overview
  9.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Market Performance
  9.9.4 Microdermics and OraSure Technologies Business Overview
  9.9.5 Microdermics and OraSure Technologies Recent Developments

10 MICRONEEDLE FLU VACCINE MARKET FORECAST BY REGION

10.1 Global Microneedle Flu Vaccine Market Size Forecast
10.2 Global Microneedle Flu Vaccine Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Microneedle Flu Vaccine Market Size Forecast by Country
  10.2.3 Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Region
  10.2.4 South America Microneedle Flu Vaccine Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Microneedle Flu Vaccine by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Microneedle Flu Vaccine Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Microneedle Flu Vaccine by Type (2025-2030)
  11.1.2 Global Microneedle Flu Vaccine Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Microneedle Flu Vaccine by Type (2025-2030)
11.2 Global Microneedle Flu Vaccine Market Forecast by Application (2025-2030)
  11.2.1 Global Microneedle Flu Vaccine Sales (Kilotons) Forecast by Application
  11.2.2 Global Microneedle Flu Vaccine Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Microneedle Flu Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Microneedle Flu Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Microneedle Flu Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2022)
Table 10. Global Market Microneedle Flu Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Microneedle Flu Vaccine Sales Sites and Area Served
Table 12. Manufacturers Microneedle Flu Vaccine Product Type
Table 13. Global Microneedle Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Microneedle Flu Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Microneedle Flu Vaccine Market Challenges
Table 22. Global Microneedle Flu Vaccine Sales by Type (Kilotons)
Table 23. Global Microneedle Flu Vaccine Market Size by Type (M USD)
Table 24. Global Microneedle Flu Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Microneedle Flu Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Microneedle Flu Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Microneedle Flu Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Microneedle Flu Vaccine Sales (Kilotons) by Application
Table 30. Global Microneedle Flu Vaccine Market Size by Application
Table 31. Global Microneedle Flu Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Microneedle Flu Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Microneedle Flu Vaccine Market Share by Application (2019-2024)
Table 35. Global Microneedle Flu Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Microneedle Flu Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Microneedle Flu Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Microneedle Flu Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Microneedle Flu Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Microneedle Flu Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Microneedle Flu Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Microneedle Flu Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Microneedle Flu Vaccine Basic Information
Table 44. Sanofi Microneedle Flu Vaccine Product Overview
Table 45. Sanofi Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Microneedle Flu Vaccine SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. GC Pharma Microneedle Flu Vaccine Basic Information
Table 50. GC Pharma Microneedle Flu Vaccine Product Overview
Table 51. GC Pharma Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GC Pharma Business Overview
Table 53. GC Pharma Microneedle Flu Vaccine SWOT Analysis
Table 54. GC Pharma Recent Developments
Table 55. Debiotech Microneedle Flu Vaccine Basic Information
Table 56. Debiotech Microneedle Flu Vaccine Product Overview
Table 57. Debiotech Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Debiotech Microneedle Flu Vaccine SWOT Analysis
Table 59. Debiotech Business Overview
Table 60. Debiotech Recent Developments
Table 61. NanoPass Technologies Microneedle Flu Vaccine Basic Information
Table 62. NanoPass Technologies Microneedle Flu Vaccine Product Overview
Table 63. NanoPass Technologies Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. NanoPass Technologies Business Overview
Table 65. NanoPass Technologies Recent Developments
Table 66. Corium International Microneedle Flu Vaccine Basic Information
Table 67. Corium International Microneedle Flu Vaccine Product Overview
Table 68. Corium International Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Corium International Business Overview
Table 70. Corium International Recent Developments
Table 71. Becton Dickinson and Company Microneedle Flu Vaccine Basic Information
Table 72. Becton Dickinson and Company Microneedle Flu Vaccine Product Overview
Table 73. Becton Dickinson and Company Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Becton Dickinson and Company Business Overview
Table 75. Becton Dickinson and Company Recent Developments
Table 76. FluGen Microneedle Flu Vaccine Basic Information
Table 77. FluGen Microneedle Flu Vaccine Product Overview
Table 78. FluGen Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. FluGen Business Overview
Table 80. FluGen Recent Developments
Table 81. CosMED Pharmaceuticals Microneedle Flu Vaccine Basic Information
Table 82. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Overview
Table 83. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CosMED Pharmaceuticals Business Overview
Table 85. CosMED Pharmaceuticals Recent Developments
Table 86. Microdermics and OraSure Technologies Microneedle Flu Vaccine Basic Information
Table 87. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Overview
Table 88. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Microdermics and OraSure Technologies Business Overview
Table 90. Microdermics and OraSure Technologies Recent Developments
Table 91. Global Microneedle Flu Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Microneedle Flu Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Microneedle Flu Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Microneedle Flu Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Microneedle Flu Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Microneedle Flu Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Microneedle Flu Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Microneedle Flu Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Microneedle Flu Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Microneedle Flu Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Microneedle Flu Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Microneedle Flu Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Microneedle Flu Vaccine Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Microneedle Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Microneedle Flu Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Microneedle Flu Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Microneedle Flu Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Microneedle Flu Vaccine Market Size by Country (M USD)
Figure 11. Microneedle Flu Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Microneedle Flu Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Microneedle Flu Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Microneedle Flu Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Microneedle Flu Vaccine Market Share by Type
Figure 18. Sales Market Share of Microneedle Flu Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Microneedle Flu Vaccine by Type in 2023
Figure 20. Market Size Share of Microneedle Flu Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Microneedle Flu Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Microneedle Flu Vaccine Market Share by Application
Figure 24. Global Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Microneedle Flu Vaccine Sales Market Share by Application in 2023
Figure 26. Global Microneedle Flu Vaccine Market Share by Application (2019-2024)
Figure 27. Global Microneedle Flu Vaccine Market Share by Application in 2023
Figure 28. Global Microneedle Flu Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Microneedle Flu Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Microneedle Flu Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Microneedle Flu Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Microneedle Flu Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Region in 2023
Figure 44. China Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Microneedle Flu Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Microneedle Flu Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Microneedle Flu Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Microneedle Flu Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Microneedle Flu Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Microneedle Flu Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Microneedle Flu Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Microneedle Flu Vaccine Market Share Forecast by Application (2025-2030)


More Publications